Detection and subtyping of human herpesvirus-8 in renal transplant patients before and after remission of Kaposi's sarcoma

Transplantation

Volumn 66, Issue 2, 1998, Pages 214-218

  Moosa, M Rafique ^a,b   Treurnicht, Florette K ^a   Van Rensbubg, Estrelita J ^a   Schneider, Johann W ^a   Jordaan, H Francois ^a   Engelbrecht, Susan ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; AUTOPSY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GENE SEQUENCE; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INDUSTRIALIZATION; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REMISSION; SKIN BIOPSY; SURVIVAL RATE; VIRUS REPLICATION;

ADULT; DNA, VIRAL; FEMALE; HERPESVIRUS 8, HUMAN; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SARCOMA, KAPOSI;

EID: 0032558135     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199807270-00013     Document Type: Article

References (37)

1. Penn I. Kaposi's sarcoma in organ transplant recipients. Transplantation 1979; 27: 8.
2. Gruber SA, Gillingham K, Sothern RB, Stephanian E, Matas AJ, Dunn DL. De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients. Clin Transplant 1994; 8: 388.
3. Farge D and the Collaborative Transplantation Research Group of Ille de France, Kaposi's sarcoma in organ transplant recipients. Bur J Med 1993; 2: 339.
4. Qunibi W, Akhtar M, Sheth K, et al. Kaposi's sarcoma: the most common tumor after renal transplantation in Saudi Arabia. Am J Med 1988; 84: 225.
5. Harwood AR, Osoba D, Hofstader SL, et al. Kaposi's sarcoma in recipients of renal transplants. Am J Med 1979; 67: 759.
6. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990; 335: 123.
7. Katz MH, Hessol NA, Buchbinder SP, Hirozawa A, O'Malley P, Holmberg SD. Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. J Infect Dis 1994; 170: 198.
8. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865.
9. Boshoff C, Whitby D, Hatziioannou T, et al. Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995; 345: 1043.
10. Huang YQ, Li JJ, Kaplan MH, et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995; 345: 759.
11. Alkan S, Karcher DS, Ortiz A, Khalil S, Akhtar M, Ali MA. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus in organ transplant patients with immunosuppression. Br J Haematol 1997; 96: 412.
12. Montagnino G, Bencini PL, Tarantino A, Caputo R, Ponticelli C. Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases. Am J Nephrol 1994; 14: 121.
13. Bencini PL, Montagnino G, Tarantino A, Alessi E, Ponticelli C, Caputo R. Kaposi's sarcoma in kidney transplant recipients. Arch Dermatol 1993; 129: 248.
14. Pedagogos E, Nicholls K, Dowling J, Becker G. Kaposi's sarcoma post renal transplantation. Aust J Med 1994; 24: 722.
15. Harawi SJ. Kaposi's sarcoma. In: Harawi SJ, O'Hara CJ, eds. Pathology and pathophysiology of AIDS and HIV-related disease. St. Louis, MO: CV Mosby, 1989: 83.
16. Friedman-Birnbaum R, Bergman R, Bitterman-Deutsch O, Weltfriend S, Lichtig C. Classic and iatrogenic Kaposi's sarcoma: histopathological patterns as related to clinical course. Am J Dermatopathol 1993; 15: 523.
17. van Rensburg EJ, Engelbrecht, S, van Heerden WFP, Raubenheimer EJ, Schoub BD. Human papillomavirus DNA in oral squamous cell carcinomas from an African population sample. Anticancer Res 1996; 16: 969.
18. Albert J, Fenyo EM, Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers. J Clin Microbiol 1990; 28: 1560.
19. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237.
20. Saiki RK, Bugawan TL, Horn GT, Mullis KB, Erlich HA. Analysis of enzymatically amplified β-globin arid HLADQα DNA with allele-specific oligonucleotide probes. Nature 1986; 324: 163.
21. Engelbrecht S, Treurnicht FK, Schneider JW, et al. Detection of human herpesvirus 8 DNA and sequence polymorphism in classical, epidemic, and iatrogenic Kaposi's sarcoma in South Africa. J Med Virol 1997; 52: 168.
22. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995; 346: 799.
23. Engelbrecht S, van Rensburg EJ. Detection of Southern African HIV-1 subtypes by PCR: evaluation of different primer pairs and conditions. J Virol Methods 1995; 55: 391.
24. Luppi M, Barozzi P, Maiorana A, et al. Frequency and distribution of herpesvirus-like DNA sequences (KSHV) in different stages of classic Kaposi's sarcoma and in normal tissue in an Italian population. Int J Cancer 1996; 6: 427.
25. Bigoni B, Dolcetti R, de Lellis L, Carbone A. Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J Infect Dis 1996; 173: 542.
26. Sears AE, Mechanisms of restriction of viral gene expression during herpes simplex virus latency. Adv Exp Med Biol 1990; 278: 211.
27. Crisan D, Mattson JC. Retrospective DNA analysis using fixed tissue specimens. DNA Cell Biol 1993; 12: 455.
28. Gao S-J, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996; 335: 233.
29. Cockburn ITR, Krupp P. The risk in neoplasms in patients treated with cyclosporine A. J Autoimmun 1989; 2: 723.
30. Dobozy A, Husz S, Hunyadi J, et al. Immune deficiencies and Kaposi's sarcoma. Lancet 1973; 2: 625.
31. Master SP, Taylor JF, Kyalwazi SK, Ziegler JL. Immunological studies in Kaposi's sarcoma in Uganda. Br Med J 1970; 1: 600.
32. Roitt IM. Essential immunology, 8th ed. Oxford: Blackwell Scientitle Publications, 1994.
33. Goust J-M, Bierer B. Cell-mediated immunity. In: Virella G, ed. Introduction to medical immunology, 3rd ed. New York: Marcel Dekker, 1993: 187.
34. Ziegler JL. Kaposi's sarcoma: introduction and overview. J AIDS 1990; 3 (suppl 1): S1.
35. Hutt MSR. Kaposi's sarcoma. Br Med Bull 1984; 40: 355.
36. Pollack MS, Safai B, Myskowski PL, Gold JW, Pandey J, Dupont B. Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma. Tissue Antigens 1983; 21: 1.
37. Dictor M, Rambech E, Way D, Witte M, Bendsöe N. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. Am J Pathol 1996; 148: 2009.